Factors that are driving the growth of narcolepsy treatment market are growing prevalence of various sleeping disorders including narcolepsy, increase in awareness about the sleep disorders. Furthermore, increasing demand for advanced diagnostics and therapeutics to treat sleeping disorders and rise in geriatric population. Narcoleptic disorder is proportionately prevalent to Parkinson’s disease, according to the WHO statistics, more than 3 million people are suffering with narcolepsy across the globe. However, stringent regulatory framework, unawareness about the disorder in underdeveloped countries, abuse usage of the drugs, delayed or undiagnosed of the narcolepsy are the few factors which are hampering the growth of narcolepsy treatment market. A sample of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-narcolepsy-treatment-market/#ulp-4H8Z4LpNMLEuOnnx[/URL]
Based on type of disorder, the narcolepsy treatment market is segmented into the following:
• Secondary Narcolepsy
• Narcolepsy with cataplexy
• Narcolepsy without cataplexy
Based on drugs, the narcolepsy treatment market is segmented into the following:
• Amphetamines
• Methylphenidate
• Modafinil
• MAO-B Inhibitors (Selegiline)
• Tricyclic Anti-Depressants (TCA)
• Selective Serotonin Reuptake Inhibitors (SSRI)
• Monoamino Oxidase Type-A (MAO-A) inhibitors
Based on distribution channel, the Narcolepsy Treatment Market is segmented into the following:
• Hospital pharmacies
• Retail Pharmacies
• Online Pharmacies
To view TOC of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-narcolepsy-treatment-market/#ulp-c654SbFYO64MsOhu[/URL]
Narcolepsy is the 3rd most common sleeping disorder which affects large group of population. Prevalence rate of narcolepsy is substantially lower in Israel i.e. 1 in 500,000 people and considerably high in Japan i.e. 1 in 600 in comparison with U.S. according to the narcolepsy network. Narcolepsy is not curable but can be treated with drugs like dextroamphetamine, methylphenidate etc. to reduce the sleep attacks. Mergers and acquisitions, collaborations, expansions to untapped geographies are the growth strategies that are adopted by the market players to enhance the market growth and to improve their product portfolio. Several voluntary organizations across the world such as Wake up Narcolepsy, Narcolepsy Network, American Sleep Association, and European Narcolepsy Network are actively involving in spreading the awareness regarding the sleeping disorders and their associated symptoms like EDS, sleep paralysis, and cataplexy.
Need more information about this report @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-narcolepsy-treatment-market/#ulp-14mlyhjMGhVjZqa3[/URL]
Some of the players in narcolepsy treatment market are Arena Pharmaceuticals, Inc.(U.S), Inc., BIOPROJET, Evotec AG (Germany), Graymark Healthcare, Inc. (U.S), Hypnion, Inc. (U.S), Ligand Pharmaceuticals, Inc.(U.S), Teva Pharmaceutical Industries Ltd.(Israel) and Jazz Pharmaceuticals, Inc.,(Ireland).
Get access to full summary @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-narcolepsy-treatment-market/[/URL]
Email: sales@precisionbusinessinsights.com
Toll Free(US): +1-866-598-1553